CTRI/2019/08/020538
Completed
未知
se of Biomarkers to Evaluate Physiological Effect of YapanaBasti on Shukra Dhatu
ConditionsHealth Condition 1: N461- Oligospermia
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: N461- Oligospermia
- Sponsor
- AYURVEDIC AND UNANI TIBBIA COLLEGE
- Enrollment
- 32
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •2\.No history of serious illness or disease
- •3\.Not under any type of medical treatment since last six months.
- •4\.Subjects having sperm count 05 to 15 million per ml (Group A)
- •5\.Subjects having sperm count More than 15 million per ml (Group B).
- •6\.Subjects who are able to come for follow up on fixed visits and are well aware about the treatment plans.
- •7\.Subjects willing to participate and able to give written informed consent
Exclusion Criteria
- •1\.Subject having Age below 20 years and more than 40 year
- •2\.Patients suffering from congenital anomalies
- •3\.Subject of Type\-I DM or Type\-II DM on insulin
- •4\.Hereditary Disease
- •5\.The patients having Varicocele, Testicular maldescent, previous reproductive surgery, STD were excluded
- •6\.Patient of Azoospermia and Aspermia.
- •7\.Taking treatment for major psychiatric problem.
- •8\.Illness necessitating long term drug treatment (Rheumatoid arthritis ,Diabetes Mellitus ,Psychoneuro endocrinal disorder ,TB,AIDS)
- •9\.Uncontrolled Hypertensive patients (BP with or without medication greater than 140/90mm Hg after 5 min of rest)
- •10\.Subjects with any unstable heart disease or known case of MI ,Unstable angina.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Exploration of biomarkers to predict the efficacy of immune checkpoint inhibitors in gastric cancer using cell-free RNA.gastric cancerJPRN-UMIN000047448Kyushu University Hospital, Department of Surgery and Science42
Completed
Not Applicable
Investigation of biomarkers for predicting effectiveness of treatments for Crohn's diseaseCrohn's diseaseJPRN-UMIN000002341Osaka University Graduate School of Medicine100
Completed
Not Applicable
Investigation of biomarkers for predicting effectiveness of treatments for inflammatory bowel diseasesinflammatory bowel diseasesJPRN-UMIN000005032Saitama medical Center, Saitama medical University200
Active, not recruiting
Phase 1
A Substudy to Explore Biomarkers of Physical Function in the Phase III Randomized, Placebo-Controlled Clinical Trial to Assess the Safety and Efficacy of Odanacatib (MK-0822) to Reduce the Risk of Fracture in Osteoporotic Postmenopausal Women Treated with Vitamin D and Calcium - Sarcopenia Sub-StudyThis is an exploratory sub-study of Protocol 018 (Eudract N°2007-002693-66) to identify biomarkers of physical function. This biomarker sub-study will use an ongoing clinical study (Protocol 018) for osteoporosis as a starting point for identification of molecular biomarkers in circulating blood for patient identification and sarcopenia progression. Patients recruited in Protocol 018 are women 65 years of age or older with osteoporosis and either 0 or 1 prior vertebral fracture.MedDRA version: 9.1 Level: LLT Classification code 10031283 Term: Osteoporosis fractureMedDRA version: 9.1 Level: LLT Classification code 10031285 Term: Osteoporosis postmenopausalEUCTR2008-005874-11-FRaboratoires Merck Sharp & Dhome-Chibret2,000
Not yet recruiting
Not Applicable
To calculate new biomarkers and its efficacy of the progresion for non-alcoholic fatty liver disease patients.non-alcoholic fatty liver disease (NAFLD)JPRN-UMIN000014550Shinshu University of Medicine600